- Home
- MRSN vs HTLM Comparison
MRSN vs HTLM Comparison
Compare MRSN & HTLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- HTLM
- Stock Information
- Founded
- MRSN 2001
- HTLM 2014
- Country
- MRSN United States
- HTLM Singapore
- Employees
- MRSN N/A
- HTLM N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- HTLM
- Sector
- MRSN Health Care
- HTLM
- Exchange
- MRSN Nasdaq
- HTLM NYSE
- Market Cap
- MRSN 71.9M
- HTLM 58.8M
- IPO Year
- MRSN 2017
- HTLM 2024
- Fundamental
- Price
- MRSN $0.33
- HTLM $3.93
- Analyst Decision
- MRSN Buy
- HTLM
- Analyst Count
- MRSN 3
- HTLM 0
- Target Price
- MRSN $4.00
- HTLM N/A
- AVG Volume (30 Days)
- MRSN 3.0M
- HTLM 27.4K
- Earning Date
- MRSN 03-03-2025
- HTLM 04-07-2025
- Dividend Yield
- MRSN N/A
- HTLM N/A
- EPS Growth
- MRSN N/A
- HTLM N/A
- EPS
- MRSN N/A
- HTLM N/A
- Revenue
- MRSN $40,497,000.00
- HTLM $4,563,246.00
- Revenue This Year
- MRSN N/A
- HTLM N/A
- Revenue Next Year
- MRSN N/A
- HTLM N/A
- P/E Ratio
- MRSN N/A
- HTLM N/A
- Revenue Growth
- MRSN 9.88
- HTLM N/A
- 52 Week Low
- MRSN $0.33
- HTLM $2.57
- 52 Week High
- MRSN $4.64
- HTLM $13.74
- Technical
- Relative Strength Index (RSI)
- MRSN 28.30
- HTLM N/A
- Support Level
- MRSN $0.41
- HTLM N/A
- Resistance Level
- MRSN $0.42
- HTLM N/A
- Average True Range (ATR)
- MRSN 0.04
- HTLM 0.00
- MACD
- MRSN -0.00
- HTLM 0.00
- Stochastic Oscillator
- MRSN 2.39
- HTLM 0.00
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.
About HTLM HOMESTOLIFE LTD
Homestolife Ltd is a home furniture retailers that offers and sells customized furniture solutions in Singapore. It has six retail store locations that sell furniture manufactured from China and other Asian countries.